Replies to post #234104 on Amarin Corp Plc (AMRN)

[JJPow]

Gus- Exactly my point. Using old V label script data and comparing it to existing Generic L label data is pointless now- aka apples to oranges. With the new label, much more insurance coverage is imminent , much larger number of patients will start V and STAY on V long term.

[iwfal]

All your stats are with the old label.

Understandable - When trigs are at a acceptable level -- stop using the drug and save money.

Now with the new label things will change.

Lots of emotions are going to take place for the next day - week - months with this investment starting Monday

1) the uptake growth over last year has been much higher than previous yrs - as a result of MACE results. So I doubt label changes it much. In fact, if anything, I’d expect compliance to go down as a higher percentage become non-true-believers.

2) I think you are misunderstanding the drug’s utility in high trig. It’s a chronic drug regardless of whether for trig or MACE.

BTW - to address a point made at the top of this thread (that ppl on this board have gotten relief from everything to hiccups to athletes foot (made up examples)), this is a board of true believers. I have zero doubt that placebo effect runs much higher in true believers. Great for them, but I wouldn’t expect it to replicate in non-believers.